Fig. 1From: The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case reportImmunohistochemical study of MS. a Expression of CD15; b expression of CD45; c expression of CD99; d expression of CD117; e expression of myeloperoxidase, f expression of BCL-2Back to article page